Who should be transplanted in first remission of acute myeloid leukaemia?

@article{Burnett2011WhoSB,
  title={Who should be transplanted in first remission of acute myeloid leukaemia?},
  author={Alan K. Burnett and Robert K. Hills},
  journal={Current treatment options in oncology},
  year={2011},
  volume={12 4},
  pages={329-40}
}
OPINION STATEMENT Patients under 40 years with other than high risk disease do not benefit from an allograft in CR1, particularly if they have received gemtuzumab ozogamicin in induction. High risk can be defined by cytogenetics (Complex; abnormalities of chromosome 5 and 7; 3q-; Ph(1)) in addition, adverse features could include presentation with high white cell count or secondary disease, or a failure to have a satisfactory blast cell reduction to induction course 1 (to <15% marrow blasts… CONTINUE READING
2 Citations
0 References
Similar Papers

Citations

Publications citing this paper.

Similar Papers

Loading similar papers…